June 8, 2023

Minoryx can start phase 3 trial for cerebral adrenoleukodystrophy patients

Spanish-headquartered Minoryx Therapeutics says the U.S. Food and Drug Administration (FDA) has approved its phase 3 clinical trial (CALYX) of lead candidate leriglitazone, to treat

Jim Cornall June 8, 2023

Cannabis

Denver weed lounge could reopen next month, inviting locals for a toke in the consumption garden – The Cannabist

Related Articles Tetra Lounge, one of Denver’s first cannabis-friendly smoking lounges, is preparing to reopen this summer after closing temporarily more than a year ago.

The Cannabist Network June 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

June 8, 2023

Minoryx can start phase 3 trial for cerebral adrenoleukodystrophy patients

Denver weed lounge could reopen next month, inviting locals for a toke in the consumption garden – The Cannabist

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe